MK Farmer

Company: Takeda

Job title: Program Lead

Seminars:

Panel Discussion | Novel Targets in Development for IgA Nephropathy: Where are the Current Late Phase Trials Heading? 11:00 am

From complement to APRIL to ETA: what targets are currently in development and looking most promising? Exploring new treatment possibilities with combinational targeting Exploring the current thinking on IgA pathogenesis to direct priorities for future target developmentRead more

day: Pre-Conference Seminar Day